The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021Feng‐Hua Wang, Rui‐Hua Xu, Xiao‐Tian Zhang et al.|Cancer Communications|2021Cited by 657
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trialXiaotian Zhang, Jiafu Ji, Lianhai Zhang et al.|The Lancet Oncology|2021Cited by 436
Variation in Gene Expression Patterns in Human Gastric CancersXin Chen, Patrick O. Brown, Suet Yi Leung et al.|Molecular Biology of the Cell|2003Cited by 319
Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trialZaozao Wang, Xiangqian Su, Jiadi Xing et al.|Surgical Endoscopy|2018Cited by 100
KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancerShuqin Jia, Jiafu Ji|PLoS ONE|2017Cited by 81